Skip to content

Effect of Tibial Nerve Stimulation in patients with Urinary Incontinence after surgery to Remove the Prostate

Percutaneous Tibial Nerve Stimulation in patients with Urinary Incontinence after Prostatectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-6qjtb4
Enrollment
Unknown
Registered
2020-01-27
Start date
2020-03-17
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Incontinence after prostatectomy

Interventions

Participants will be randomized randomly between intervention group and control group. Intervention group: 24 men with urinary incontinence after prostatectomy assessed by the pad test at the time of
Other
E05.723.402

Sponsors

Universidade Federal de Ciências da Saúde de Porto Alegre
Lead Sponsor
Universidade Federal de Ciências da Saúde de Porto Alegre
Collaborator

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Men who underwent radical prostatectomy with urinary incontinence after the cateter removal, defined by a volume greater than 1.0 gram on the pad test and who agreed to participate in the research

Exclusion criteria

Exclusion criteria: Men who are using anticholinergics, tricyclic antidepressants, who have neurological disorders or urethral stricture. Men with complications such as radiotherapy will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Reduction in the volume of postoperative urinary incontinence measured in grams determined by pre- and post-intervention pad testing, from finding at least 5% variation in pre- and post-intervention measurements

Secondary

MeasureTime frame
Improvement of quality of life indicator assessed by score from quality of life questionnaire in cancer individuals, from finding at least 5% variation in pre- and post-intervention measurements;Reduction of overactive bladder symptoms assessed by score from validated overactive bladder questionnaire, from finding at least 5% variation in pre- and post-intervention measurements;Improvement of erectile function assessed by score obtained from validated erectile function questionnaire, from finding at least 5% variation in pre- and post-intervention measurements

Countries

Brazil

Contacts

Public ContactJordana Fernandes

Universidade Federal de Ciências da Saúde de Porto Alegre

jordana_fernandes@yahoo.com.br+5551998840673

Outcome results

None listed

Source: REBEC (via WHO ICTRP)